Widow Speaks Out on Long-delayed COVID Injury Claims
The focus of the [Countermeasures Injury Compensation Program] right now is to help reimburse people impacted by COVID-related treatments. There are more than 13,000 claims from people say they were injured in some way by a countermeasure or a treatment for COVID that the government asked its citizens to take. And while most of those claims […]
Cardiac Deaths Have Increased 17 Percent in Years Following the COVID-19 Pandemic
A new population-based study conducted by researchers at Harvard-affiliated Mass General Brigham has found that cardiac deaths have increased significantly since the onset of the COVID-19 pandemic, with many occurring in homes rather than hospitals. Published May 30, 2025 in JAMA Network Open, the study offers one of the most comprehensive analyses to date examining […]
FDA Approves Yeztugo as Injectable Product to Prevent HIV in Adults and Adolescents
Last week, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir), the company’s injectable HIV-1 capsid inhibitor, for use as pre-exposure prophylaxis (PrEP). Yeztugo is not labeled a “vaccine” but is a pharmaceutical product intended to reduce the risk of acquiring human immunodeficiency virus (HIV) via sexual activity […]
Did Covid Vaccines Really Save Millions?
Two years have passed since the official end of the Covid-19 pandemic, yet the topic of vaccination remains highly sensitive in both public and scientific discourse. Attempts to question the legitimacy of the mass vaccination campaign or to raise concerns about potential harms are often met with a moral red line: the widely repeated claim […]
Vindication for the Unvaccinated?
At a recent family gathering, I sat at the dinner table with a group of loved ones for the first time since the Covid-19 fiasco. Most of the cheerful discussion focused on the spectacular event of the week: my mother’s 100th birthday. I was the only person at the table who hadn’t had any form […]
Improving Science & Restoring Trust in Public Health | Jay Bhattacharya, MD
A substantial part of the NIH portfolio, appropriately, focuses on basic science. Basic science meaning fundamental biological facts that can be used in many many drug studies, other research where you don’t necessarily know specifically in advance when you’re doing it what the application’s going to be. The NIH, very appropriately, funds that work, especially […]